Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aerosol Particle Size Influences the Infectious Dose and Disease Severity in a Golden Syrian Hamster Model of Inhalational COVID-19.

Journal of aerosol medicine and pulmonary drug delivery·2023
Same author

SARS-CoV-2 is rapidly inactivated at high temperature.

Environmental chemistry letters·2021
Same author

Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces.

mSphere·2020
Same author

Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models.

Frontiers in immunology·2019
Same author

Complete Genome Sequence of the Embu Virus Strain SPAn880.

Genome announcements·2014
Same author

Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran.

Genome announcements·2014

Related Experiment Video

Updated: Jul 10, 2026

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Genomic differences between guinea pig lethal and nonlethal Marburg virus variants.

Loreen L Lofts1, M Sofi Ibrahim, Diane L Negley

  • 1Viral Pathogenesis and Immunology Branch, Virology Division, US Army Medical Research Institute for Infectious Diseases, Frederick, MD 21702, USA. loreen.lofts@us.army.mil

The Journal of Infectious Diseases
|December 6, 2007
PubMed
Summary

Marburg virus (MARV) genome sequencing revealed few genetic differences between highly lethal and less virulent strains. Key mutations in matrix protein VP40 and RNA-dependent RNA polymerase (L) explain virulence variations.

More Related Videos

Measurement of γHV68 Infection in Mice
13:22

Measurement of γHV68 Infection in Mice

Published on: November 22, 2011

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

Related Experiment Videos

Last Updated: Jul 10, 2026

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Measurement of γHV68 Infection in Mice
13:22

Measurement of γHV68 Infection in Mice

Published on: November 22, 2011

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

Area of Science:

  • Virology
  • Genomics
  • Molecular Biology

Background:

  • Marburg virus (MARV) causes severe hemorrhagic fever.
  • Understanding genetic determinants of MARV virulence is crucial for disease control.

Purpose of the Study:

  • To identify genetic differences between two closely related MARV variants with distinct virulence in guinea pigs.
  • To pinpoint specific mutations responsible for observed differences in pathogenicity.

Main Methods:

  • Whole-genome sequencing of two MARV variants (Lake Victoria marburgvirus, strain Musoke).
  • Comparative analysis of coding and noncoding RNA regions.
  • Identification of amino acid-altering mutations and silent codon changes.

Main Results:

  • Only a few genomic regions differentiated the two MARV variants.
  • Four amino acid-changing mutations were found: one in VP40 and three in the L gene.
  • Mutations in VP40 occurred in a nonconserved loop, while L gene mutations were near a conserved polymerase motif.

Conclusions:

  • Limited genetic variations underlie significant virulence differences in MARV.
  • Specific mutations in VP40 and L genes are likely responsible for altered pathogenicity.
  • Further research into these specific mutations can inform MARV therapeutics.